Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 60 /hr
Hire Dr. Jitendra K.
United States
USD 60 /hr
15+ years in Bioenergetics and Gene Expression, focusing on Host-Viral interactions through advanced in vivo research
Profile Summary
Subject Matter Expertise
Services
Writing
Medical Writing
Research
Scientific and Technical Research,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Product Development
Formulation,
Prototyping
Work Experience
Post Doc Fellow
Mayo Clinic
December 2023 - Present ![]()
Researcher
Institute of Liver and Biliary Sciences
January 2017 - June 2023 ![]()
Education
Ph.D. (Biomedical Sciences )
Institute of Liver and Biliary Sciences
January 2017 - June 2023 ![]()
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Purnima Tyagi, Ankita Singh, Jitendra Kumar, Belal Ahmad, Aparna Bahuguna, Perumal Vivekanandan, Shiv Kumar Sarin, Vijay Kumar (2024). Furanocoumarins promote proteasomal degradation of viral HBx protein and down-regulate cccDNA transcription and replication of hepatitis B virus . Virology.
Jitendra Kumar, Ph.D. (2023). A Prospective: Hepatitis B Virus X Protein could be a Therapeutic Target for the Cure of Hepatitis B Virus Infection . Biology and Medicine.
Ankita Singh, Jitendra Kumar, Vijay Kumar (2023). Chronic Hepatitis B Infection: Current and Emerging Therapeutic Strategies . Current Topics in Medicinal Chemistry.
Sukriti Baweja, Anupama Kumari, Preeti Negi, Arvind Tomar, Dinesh Mani Tripathi, Akash Kumar Mourya, Aayushi Rastogi, P. Debishree Subudhi, Swati Thangariyal, Guresh Kumar, et al.(2023). Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod . Journal of Hepatology. Elsevier {BV}
Purnima Tyagi, Akhilesh Kumar Saini, Jitendra Kumar.(2023). Dynamic Regulation of MALAT1 in Leader Cell Formation and Collective Cancer Invasion . Journal of Analytical Techniques and Research. 05. (03). Fortune Journals
Jitendra Kumar, Ph.D.(2020). Bioenergetics defect of CD14+ monocytes are associated with increased mortality in acute liver failure . Journal of Hepatology. 73. p. S221--S222. Elsevier {BV}
Jitendra Kumar, Ph.D.(2019). Modification Patterns of Urinary Albumin Correlates With Serum Albumin and Outcome in Severe Alcoholic Hepatitis . Journal of Clinical Gastroenterology. 53. (6). p. e243--e252. Ovid Technologies (Wolters Kluwer Health)
Das, S., Hussain, M.S., Maras, J.S., Kumar, J., Shasthry, S.M., Nayak, S., Arora, V., Vijayaraghavan, R., Sharma, S., Maiwall, R., et al.(2019). Modification Patterns of Urinary Albumin Correlates with Serum Albumin and Outcome in Severe Alcoholic Hepatitis . Journal of Clinical Gastroenterology. 53. (6). p. E243-E252.
Jitendra Kumar, Ph.D. (2018). Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis . Scientific reports.
Maras, J.S., Das, S., Sharma, S., Sukriti, S., Kumar, J., Vyas, A.K., Kumar, D., Bhat, A., Yadav, G., Choudhary, M.C., et al.(2018). Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis . Scientific Reports. 8. (1).
PREPRINT
Jitendra Kumar, Purnima Tyagi, Manisha Yadav, Deepti Sharma, Jaswinder Singh Maras, Vijay Kumar (2023). Analytical Method Development for Evaluation of Pharmacokinetics and Tissue Distribution of Thiourea-Based Antivirals through nLC/MS-MS .
Jitendra Kumar, Purnima Tyagi, akhilesh kumar saini, Deepti Sharma, Vijay Kumar (2023). Safety Assessment and Evaluation of Novel Thiourea Derivatives as Antivirals .
Jitendra Kumar, Purnima Tyagi, Akhilesh Kumar Saini, Deepti Sharma, Jaswinder Singh Maras, Vijay Kumar (2023). Thiourea Derivatives Rejuvenate Dysfunctional Mitochondria in Chronic Hepatitis B Infection .
Jitendra Kumar, Purnima Tyagi, Akhilesh Kumar Saini, Deepti Sharma, Jaswinder Singh Maras, Vijay Kumar (2023). Thiourea Derivatives Rejuvenate Mitochondria and Provide Anti-viral Activity Against Chronic Hepatitis B Infection .
Jitendra Kumar, Ph.D.(2022). Targeted HBx gene editing by CRISPR/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells . []. Research Square Platform {LLC}
OTHER
Rawal, P., Tripathi, D.M., Hemati, H., Kumar, J., Sarin, S.K., Nain, V., Kaur, S.(2022). Targeted HBx gene editing by CRISPR/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells . ResearchSquare.
BOOK CHAPTER
Kumar, J., Kumar, V.(2021). Ribosome proteins-Their balanced production . Emerging Concepts in Ribosome Structure, Biogenesis, and Function. p. 47-87.